Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05530408 · ClinicalTrials.gov registry record
Quantitative Pulmonary Imaging Registry & Biorepository
A clinical trial of Pulmonary Disease, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05530408: Recruiting study of Pulmonary Disease, sponsored by University of Kansas Medical Center.
NCT05530408 is a study of Pulmonary Disease that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 100 participants, below the 620-participant average among 19 other Pulmonary Disease trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05530408, a study of Pulmonary Disease, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological significance of imaging biomarkers. This registry and biorepository will accelerate the development of these imaging techniques and may lead toward future clinical adoption of quantitative pulmonary imaging.
Primary Outcome
Collect relevant medical history (including demographic information, diagnoses, medical tests, smoking history), for patients participating in pulmonary imaging research.
Conditions Studied
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-05-24 |
| Est. Completion | 2028-05-31 |
What NCT05530408 shows while recruiting
NCT05530408 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 620-participant average among 19 other Pulmonary Disease trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05530408 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT05530408 about?
NCT05530408 is a clinical study titled "Quantitative Pulmonary Imaging Registry & Biorepository". The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological ...
What is the current status of trial NCT05530408?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-05-24. Estimated completion is 2028-05-31.
What conditions does trial NCT05530408 study?
This clinical trial studies the following conditions: Pulmonary Disease.
Who is sponsoring clinical trial NCT05530408?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05530408 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05530408's enrollment target sits among peer trials
100 11th of 19 higher than 8 of 19 other Pulmonary Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
RECRUITING
-
Merck IIT: RRP Pembro and Lenvatinib
RECRUITING · Early Phase 1
-
Study of Lung Proteins in Patients With Pneumonia
RECRUITING
-
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
RECRUITING
-
Risk Underlying Rural Areas Longitudinal Cohort Study (RURAL) Heart and Lung Study
RECRUITING
-
Cooperative Assessment of Late Effects for SCD Curative Therapies
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI